The role of the multidisciplinary tumor board after endoscopic resection of malignant tumors: is it worth it?
Colorectal cancer
Early gastric cancer
Endoscopic full-thickness resection
Endoscopic mucosal resection
Endoscopic submucosal dissection
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
10
08
2023
accepted:
20
10
2023
medline:
22
11
2023
pubmed:
22
11
2023
entrez:
22
11
2023
Statut:
aheadofprint
Résumé
The value of multidisciplinary tumor boards (MTBs) in the treatment of gastrointestinal cancer patients is well known. Most of the current evidence focuses on advanced cancer cases, whereas little is known about the effect of MTBs on early tumors, especially after endoscopic resection. The aim of our study is to evaluate the value of the MTB after endoscopic resection of malignant tumors of the gastrointestinal tract. We retrospectively analyzed all endoscopically resected malignant tumors in our department between 2011 and 2019, focusing on the existence of an MDT recommendation after endoscopic resection, the MDT adherence to the current guidelines, and the implementation of the recommendation by the patients. We identified 198 patients fulfilling our inclusion criteria, of whom 168 (85%) were discussed in the MDT after endoscopic resection. In total, 155 of the recommendations (92%) were in accordance with the current guidelines, and 147 (88%) of them were implemented by the patients. The MDT discussion itself did not influence the overall survival, whereas the implementation of the MTB recommendation was associated with a significantly better prognosis. Deviations of the MDT recommendation from the guidelines had no effect on the overall survival. The discussion of endoscopically resected malignant tumors in the MTB is crucial for the treatment of patients with this type of cancer, since the implementation of the MTB recommendation, even if it deviates from the current guidelines, improves the prognosis.
Identifiants
pubmed: 37991571
doi: 10.1007/s00464-023-10555-3
pii: 10.1007/s00464-023-10555-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
AlFarhan H, Algwaiz G, Alzahrani H, Alsuhaibani R, Alolayan A, Abdelhafiz N, Ali Y, Boghdadly S, Jazieh A (2018) Impact of GI tumor board on patient management and adherence to guidelines. J Glob Oncol. https://doi.org/10.1200/JGO.17.00164
doi: 10.1200/JGO.17.00164
pubmed: 30241257
pmcid: 6223466
Milligan W (1922) Discussion on the treatment of malignant growths of the nasal accessory sinuses. Proc R Soc Med 15:44
pubmed: 19982340
pmcid: 2102866
Basta Y, Baur O, van Dieren S, Klinkenbijl J, Fockens P, Tytgat K (2016) Is there a benefit of multidisciplinary cancer team meetings for patients with gastrointestinal malignancies? Ann Surg Oncol 23:2430–2437. https://doi.org/10.1245/S10434-016-5178-3
doi: 10.1245/S10434-016-5178-3
pubmed: 27002814
pmcid: 4927602
Schmiegel W, Buchberger B, Follmann M, Graeven U, Heinemann V, Langer T, Nothacker M, Porschen R, Rödel C, Rösch T, Schmitt W, Wesselmann S, Pox C (2017) S3-Leitlinie—Kolorektales Karzinom. Z Gastroenterol 55:1344–1498. https://doi.org/10.1055/S-0043-121106
doi: 10.1055/S-0043-121106
pubmed: 29212104
Oxenberg J, Papenfuss W, Esemuede I, Attwood K, Simunovic M, Kuvshinoff B, Francescutti V (2015) Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable treatment changes: a prospective study of 149 consecutive patients. Ann Surg Oncol 22:1533–1539. https://doi.org/10.1245/S10434-014-4163-Y
doi: 10.1245/S10434-014-4163-Y
pubmed: 25323473
Munro A, Brown M, Niblock P, Steele R, Carey F (2015) Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer. https://doi.org/10.1186/S12885-015-1683-1
doi: 10.1186/S12885-015-1683-1
pubmed: 26463599
pmcid: 4604766
Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, van Grieken NCT, Vogel A, Smyth EC (2022) Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33:992–1004. https://doi.org/10.1016/J.ANNONC.2022.07.003
doi: 10.1016/J.ANNONC.2022.07.003
pubmed: 35914638
Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, Vogel A, Smyth EC (2022) Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33:1005–1020. https://doi.org/10.1016/J.ANNONC.2022.07.004
doi: 10.1016/J.ANNONC.2022.07.004
pubmed: 35914639
Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, Van Hooft JE, Deprez PH, Dinis-Ribeiro M (2022) Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) guideline—update 2022. Endoscopy 54:591–622. https://doi.org/10.1055/A-1811-7025
doi: 10.1055/A-1811-7025
pubmed: 35523224
Ryan J, Faragher I (2014) Not all patients need to be discussed in a colorectal cancer MDT meeting. Colorectal Dis 16:520–526. https://doi.org/10.1111/CODI.12581
doi: 10.1111/CODI.12581
pubmed: 24617857
Parker J, Gupta S, Torkington J, Dolwani S (2021) Multidisciplinary decision-making strategies may reduce the need for secondary surgery in complex colonic polyps—a systematic review and pooled analysis. Colorectal Dis 23:3101–3112. https://doi.org/10.1111/CODI.15901
doi: 10.1111/CODI.15901
pubmed: 34473891
Croke J, El-Sayed S (2012) Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr Oncol. https://doi.org/10.3747/CO.19.944
doi: 10.3747/CO.19.944
pubmed: 23144581
pmcid: 3457884
Walraven J, Desar I, van der Hoeven J, Aben K, van Hillegersberg R, Rasch C, Lemmens V, Verhoeven R (2019) Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands. Eur J Cancer 121:85–93. https://doi.org/10.1016/J.EJCA.2019.08.007
doi: 10.1016/J.EJCA.2019.08.007
pubmed: 31563730
Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3:219–225. https://doi.org/10.1007/PL00011720
doi: 10.1007/PL00011720
pubmed: 11984739
Zwager LW, Bastiaansen BAJ, Montazeri NSM, Hompes R, Barresi V, Ichimasa K, Kawachi H, Machado I, Masaki T, Sheng W, Tanaka S, Togashi K, Yasue C, Fockens P, Moons LMG, Dekker E (2022) Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis. Gastroenterology 163:174–189. https://doi.org/10.1053/J.GASTRO.2022.04.010
doi: 10.1053/J.GASTRO.2022.04.010
pubmed: 35436498
Kneist W, Terzic A, Burghardt J, Heintz A, Junginger T (2004) Selektion von patienten mit rektumtumoren zur lokalen exzision aufgrund der präoperativen diagnostik: Ergebnisse einer konsekutiven erfassungsstudie von 552 patienten. Chirurg 75:168–175. https://doi.org/10.1007/s00104-003-0746-z
doi: 10.1007/s00104-003-0746-z
pubmed: 14991179
Serra-Aracil X, Caro-Tarrago A, Mora-López L, Casalots A, Rebasa P, Navarro-Soto S (2014) Transanal endoscopic surgery with total wall excision is required with rectal adenomas due to the high frequency of adenocarcinoma. Dis Colon Rectum 57(7):823–829
Berardi R, Morgese F, Rinaldi S, Torniai M, Mentrasti G, Scortichini L, Giampieri R (2020) Benefits and limitations of a multidisciplinary approach in cancer patient management. Cancer Manag Res 12:9363–9374. https://doi.org/10.2147/CMAR.S220976
doi: 10.2147/CMAR.S220976
pubmed: 33061625
pmcid: 7533227
Saito Y, Sakamoto T, Fukunaga S, Nakajima T, Kuriyama S, Matsuda T (2009) Endoscopic submucosal dissection (ESD) for colorectal tumors. Dig Endosc 21(Suppl 1):S7–S12
pubmed: 19691740
Asayama N, Oka S, Tanaka S, Hayashi N, Arihiro K, Chayama K (2015) Endoscopic submucosal dissection as total excisional biopsy for clinical T1 colorectal carcinoma. Digestion 91(1):64–69
doi: 10.1159/000368866
pubmed: 25632920
Wagner A, Neureiter D, Kiesslich T, Wolkersdörfer GW, Pleininger T, Mayr C, Dienhart C, Yahagi N, Oyama T, Berr F (2018) Single-center implementation of endoscopic submucosal dissection (ESD) in the colorectum: Low recurrence rate after intention-to-treat ESD. Dig Endosc 30:354–363. https://doi.org/10.1111/den.12995
doi: 10.1111/den.12995
pubmed: 29218732
Hoinville L, Taylor C, Zasada M, Warner R, Pottle E, Green J (2019) Improving the effectiveness of cancer multidisciplinary team meetings: analysis of a national survey of MDT members’ opinions about streamlining patient discussions. BMJ Open Qual. https://doi.org/10.1136/BMJOQ-2019-000631
doi: 10.1136/BMJOQ-2019-000631
pubmed: 31259288
pmcid: 6567952
Munro A (2015) Multidisciplinary team meetings in cancer care: an idea whose time has gone? Clin Oncol (R Coll Radiol) 27:728–731. https://doi.org/10.1016/J.CLON.2015.08.008
doi: 10.1016/J.CLON.2015.08.008
pubmed: 26365047
Lamb B, Jalil R, Sevdalis N, Vincent C, Green J (2014) Strategies to improve the efficiency and utility of multidisciplinary team meetings in urology cancer care: a survey study. BMC Health Serv Res. https://doi.org/10.1186/1472-6963-14-377
doi: 10.1186/1472-6963-14-377
pubmed: 25196248
pmcid: 4162937
Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ (2013) Tumor boards and the quality of cancer care. J Natl Cancer Inst 105:113–121. https://doi.org/10.1093/JNCI/DJS502
doi: 10.1093/JNCI/DJS502
pubmed: 23274388
pmcid: 4481638
Agarwal PD, Phillips P, Hillman L, Lucey MR, Lee F, Mezrich JD, Said A (2017) Multidisciplinary management of hepatocellular carcinoma improves access to therapy and patient survival. J Clin Gastroenterol 51:845–849. https://doi.org/10.1097/MCG.0000000000000825
doi: 10.1097/MCG.0000000000000825
pubmed: 28877082
Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. https://doi.org/10.1136/BMJ.E2718
doi: 10.1136/BMJ.E2718
pubmed: 22539013
pmcid: 3339875
Trautmann F, Reißfelder C, Pecqueux M, Weitz J, Schmitt J (2018) Evidence-based quality standards improve prognosis in colon cancer care. Eur J Surg Oncol 44:1324–1330. https://doi.org/10.1016/J.EJSO.2018.05.013
doi: 10.1016/J.EJSO.2018.05.013
pubmed: 29885983
Somashekhar SP, Sepúlveda MJ, Puglielli S, Norden AD, Shortliffe EH, Rohit Kumar C, Rauthan A, Arun Kumar N, Patil P, Rhee K, Ramya Y (2018) Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol 29:418–423. https://doi.org/10.1093/ANNONC/MDX781
doi: 10.1093/ANNONC/MDX781
pubmed: 29324970
Brauer D, Strand M, Sanford D, Kushnir V, Lim K, Mullady D, Tan B, Wang-Gillam A, Morton A, Ruzinova M, Parikh P, Narra V, Fowler K, Doyle M, Chapman W, Strasberg S, Hawkins W, Fields R (2017) Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study. HPB (Oxford) 19:133–139. https://doi.org/10.1016/J.HPB.2016.11.002
doi: 10.1016/J.HPB.2016.11.002
pubmed: 27916436
Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Yamanouchi K, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Hayashi Y, Nakaya N, Nakamura T, Shimosegawa T (2017) A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: “eCura system.” Am J Gastroenterol. https://doi.org/10.1038/AJG.2017.95
doi: 10.1038/AJG.2017.95
pubmed: 28397873
Sun F, Gerrard G (2016) Cancer multidisciplinary teams can be a valuable and an effective use of a clinician’s time. Clin Oncol (R Coll Radiol) 28:410. https://doi.org/10.1016/J.CLON.2016.01.015
doi: 10.1016/J.CLON.2016.01.015
pubmed: 26880061
Gashin L, Tapper E, Babalola A, Lai K, Miksad R, Malik R, Cohen E (2014) Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinoma. HPB (Oxford) 16:1009–1015. https://doi.org/10.1111/HPB.12280
doi: 10.1111/HPB.12280
pubmed: 24888730
Basta Y, Bolle S, Fockens P, Tytgat K (2017) The value of multidisciplinary team meetings for patients with gastrointestinal malignancies: a systematic review. Ann Surg Oncol 24:2669–2678. https://doi.org/10.1245/S10434-017-5833-3
doi: 10.1245/S10434-017-5833-3
pubmed: 28337661
pmcid: 5539280
Wood J, Metcalfe C, Paes A, Sylvester P, Durdey P, Thomas M, Blazeby J (2008) An evaluation of treatment decisions at a colorectal cancer multi-disciplinary team. Colorectal Dis 10:769–772. https://doi.org/10.1111/J.1463-1318.2007.01464.X
doi: 10.1111/J.1463-1318.2007.01464.X
pubmed: 18215197